Immunotherapy for Previously Treated Advanced Non-Small Cell Lung Cancer

Immunotherapy for Previously Treated Advanced Non-Small Cell Lung Cancer

Da: GRACEcast
0 0 5 anni fa
Immune checkpoint inhibitors are now becoming approved and commercially available for patients with previously treated advanced NSCLC. Dr. Eddie Garon, medical oncologist at UCLA, summarizes key data and explains their current role in treatment.

Seguici su Facebook